Corvus Pharmaceuticals, Inc. (CRVS)
USD 4.7
(-36.4%)
USD 4.7
(-36.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 151 Thousand | 367 Thousand | 460 Thousand | 632 Thousand | 743 Thousand | 847 Thousand |
| Gross Profit | -151 Thousand | -367 Thousand | -460 Thousand | -632 Thousand | -743 Thousand | -847 Thousand |
| Operating Expenses | 23.4 Million | 32.56 Million | 38.63 Million | 43.76 Million | 48.85 Million | 49.22 Million |
| Selling, General and Administrative Expenses | 6.73 Million | 8.09 Million | 9.51 Million | 11.93 Million | 10.87 Million | 10.63 Million |
| Research and Development Expenses | 16.52 Million | 24.46 Million | 29.11 Million | 31.83 Million | 37.97 Million | 38.58 Million |
| Other Expenses | - | 587 Thousand | 235 Thousand | 37.45 Million | - | - |
| Cost and Expenses | 23.4 Million | 32.56 Million | 38.63 Million | 43.76 Million | 48.85 Million | 49.22 Million |
| Operating Income | -23.32 Million | -32.56 Million | -38.63 Million | -43.76 Million | -48.85 Million | -49.22 Million |
| Interest Expense | 1.58 Million | 654 Thousand | 15 Thousand | 540 Thousand | 2.18 Million | 2.28 Million |
| Income Tax Expense | - | 8.74 Million | -5.04 Million | -1.17 Million | -2.92 Million | 2.28 Million |
| Earnings before Tax | -27.02 Million | -41.3 Million | -43.24 Million | -5.99 Million | -46.67 Million | -46.93 Million |
| Net Income | -27.02 Million | -50.04 Million | -38.2 Million | -4.82 Million | -43.74 Million | -46.93 Million |
| Earnings Per Share Basic | -0.56 | -1.08 | -0.91 | -0.16 | -1.49 | -1.71 |
| Earnings Per Share Diluted | -0.56 | -1.08 | -0.91 | -0.16 | -1.49 | -1.71 |
| Weighted Average Shares Outstanding | 48.02 Million | 46.55 Million | 41.85 Million | 29.47 Million | 29.34 Million | 27.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.02 Million | 46.55 Million | 41.85 Million | 29.47 Million | 29.34 Million | 27.5 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -26.87 Million | -40.94 Million | -42.78 Million | -5.36 Million | -48.85 Million | -46.09 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 246 Thousand | - | - |
| Cost of Revenue | 21 Thousand | 23 Thousand | 151 Thousand | 28 Thousand | 30 Thousand | 36 Thousand |
| Gross Profit | -21 Thousand | -23 Thousand | -151 Thousand | 218 Thousand | -30 Thousand | -36 Thousand |
| Operating Expenses | 5.91 Million | 6.23 Million | 23.25 Million | 5.62 Million | 5.56 Million | 5.62 Million |
| Selling, General and Administrative Expenses | 1.8 Million | 2.15 Million | - | 1.62 Million | 1.59 Million | 1.65 Million |
| Research and Development Expenses | 4.11 Million | 4.07 Million | - | 3.99 Million | 3.96 Million | 3.96 Million |
| Other Expenses | - | - | - | 22 Thousand | - | - |
| Cost and Expenses | 5.93 Million | 6.25 Million | 23.4 Million | 5.65 Million | 5.56 Million | 5.62 Million |
| Operating Income | -5.93 Million | -6.25 Million | -23.4 Million | -5.65 Million | -5.56 Million | -5.62 Million |
| Interest Expense | 434 Thousand | 316 Thousand | 1.58 Million | 380 Thousand | 425 Thousand | 403 Thousand |
| Income Tax Expense | - | -20.27 Thousand | - | -95 Thousand | -425 Thousand | -403 Thousand |
| Earnings before Tax | -4.26 Million | -5.7 Million | -27.02 Million | -6.65 Million | -6 Million | -6.5 Million |
| Net Income | -4.26 Million | -5.7 Million | -27.02 Million | -6.65 Million | -6 Million | -6.5 Million |
| Earnings Per Share Basic | -0.07 | -0.12 | - | -0.14 | -0.12 | -0.14 |
| Earnings Per Share Diluted | -0.07 | -0.12 | - | -0.14 | -0.12 | -0.14 |
| Weighted Average Shares Outstanding | 59.71 Million | 49.03 Million | 48.02 Million | 49.03 Million | 48.97 Million | 47.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.71 Million | 49.03 Million | 48.02 Million | 49.03 Million | 48.97 Million | 47.49 Million |
| Gross Margin | - | - | - | 0.89 | - | - |
| EBIT Margin | - | - | - | -22.86 | - | - |
| Profit Margin | - | - | - | -27.04 | - | - |
| EBITDA | -5.91 Million | -6.23 Million | - | -5.62 Million | -5.53 Million | -5.58 Million |
| Earnings Before Tax Margin | - | - | - | -22.97 | - | - |
600558
SGSOF
KISB
LGIH
HRL
0172